denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Vertex Pharmaceuticals and Chiesi USA
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Diseases, Therapies
Hematology Disease Topics & Pathways:
Diseases, Therapies
Friday, December 8, 2023: 3:00 PM-6:00 PM
Room 6B
(San Diego Convention Center)
Chair:
Biree Andemariam, MD, University of Connecticut Health
Disclosures:
Andemariam: Accordant: Consultancy; Afimmune: Consultancy; Agios: Consultancy; American Society of Hematology: Research Funding; Bluebird: Consultancy; Connecticut Department of Public Health: Research Funding; Emmaus: Consultancy; Forma Therapeutics: Consultancy, Research Funding; Global Blood Therapeutics: Consultancy, Research Funding; GSK: Consultancy; Hemanext: Consultancy, Research Funding; HRSA: Research Funding; Novartis: Consultancy, Research Funding; NovoNordisk: Consultancy; PCORI: Research Funding; Pfizer: Research Funding; Sanofi Genzyme: Consultancy; Vertex: Consultancy.
Speakers:
Nirmish Shah, MD, Duke University Medical Center
and
Lydia H Pecker, MD, Johns Hopkins University School of Medicine
Disclosures:
Shah: Agios Pharmaceuticals: Consultancy; Global Blood Therapeutics/Pfizer: Consultancy, Research Funding, Speakers Bureau; Alexion Pharmaceuticals: Speakers Bureau; Vertex: Consultancy; Bluebird bio: Consultancy; Forma: Consultancy. Pecker: Novo Nordisk: Consultancy; Global Blood Therapeutics: Consultancy; Alexion: Research Funding.
This educational activity will explore disease management approaches in SCD by focusing on
important components of successful pain management, the challenges of complications and
comorbid conditions in patients with SCD, the changing needs of patients across the lifespan
including issues pertaining to reproductive and sexual health, and the evolving treatment
landscape for patients with SCD.